Preoperatively assessed as stage III according to the 8th edition UICC/AJCC staging system.
Deemed eligible for radical resection upon investigator assessment.
No prior anti-tumor therapy received.
ECOG PS score 0-1.
Willing and able to provide signed informed consent for participation in the study.
You may not be if
Has a history of other malignant tumors.
Pregnant and lactating women.
Presence of any concurrent medical or psychiatric condition, as assessed by the investigator, that may interfere with protocol compliance, study follow-up, or affect short-term survival.
Clareo Health | A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer
